AFP — AFT Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$273.81m
- AU$305.70m
- NZ$156.64m
- 87
- 27
- 48
- 56
2019 March 31st | 2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash from Operating Activities | 1.07 | 14.9 | 0.75 | 14.2 | 11.6 |
Capital Expenditures | -3.46 | -6.56 | -6.23 | -5.58 | -9.18 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1.42 | 0 | — | — | — |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -4.88 | -6.56 | -6.23 | -5.58 | -9.18 |
Financing Cash Flow Items | -3.56 | -5.9 | -4.19 | -2.19 | -2.86 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.72 | -9.12 | 2.52 | -2.28 | -6.98 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.146 | -0.797 | -2.91 | 6.39 | -4.65 |